The largest database of trusted experimental protocols

Gateway cloning

Manufactured by Thermo Fisher Scientific
Sourced in United States, United Kingdom, Switzerland

Gateway cloning is a molecular biology technique that allows for the efficient transfer of DNA sequences between multiple expression vectors. It is a site-specific recombination system that enables the unidirectional cloning of DNA fragments into various destinations without the need for restriction enzyme digestion or ligation.

Automatically generated - may contain errors

245 protocols using gateway cloning

1

Generation and Characterization of Tagged Transcription Regulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
For generation of pcDNA5/TO/FRT-3x-FLAG-PIAS1 complementary cDNA from CMV-3x-FLAG-PIAS1 was inserted as BamHI fragments into pcDNA5/TO (Invitrogen) backbone. For generation of N-terminally BirA*-tagged GR3KR (pcDNA5-FRT-TO-HA-BirA-GR3KR), cDNA of the human GR isoform alpha mutant (K277,293,703R) (20 (link)) was transferred with Gateway-cloning (Invitrogen) to the destination vector pcDNA5-FRT-TO-HA-BirA-GW (gift from Dr. Maria Vartiainen, University of Helsinki, Finland) as previously described (21 (link)). For generation of the N-terminally EGFP-tagged NCOA1, cDNA of the human NCOA1 isoform SRC1a from pSG5-SRC1a (22 (link)) (gift from Dr. Parker, Imperial Cancer Research Fund, London, UK) was transferred with Gateway-cloning (Invitrogen) to the destination vector pDest-C1-EGFP-GW (gift from Dr. Maria Vartiainen, University of Helsinki, Finland). The cloning services of the Genome Biology Unit (GBU) at the University of Helsinki were used for generation of the N-terminally mCherry-tagged GRwt and GR3KR constructs. Briefly, cDNA of the human GR isoform alpha and its 3KR mutant were transferred with Gateway-cloning (Invitrogen) to the destination vector mCherry-GW. All plasmids were verified by sequencing.
+ Open protocol
+ Expand
2

Yeast Expression of Human GCK and GKRP

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pancreatic isoform of human GCK (Ensembl ENST00000403799.8) was codon optimized for yeast expression and cloned into pDONR221 (Genscript). The initial test set GCK variants were generated by Genscript. For yeast expression, WT GCK, test set variants and libraries were cloned into pAG416GPD-EGFP-ccdB (Addgene plasmid # 14,316; http://n2t.net/addgene:14316; RRID:Addgene_14316, [92 (link)]) using Gateway cloning (Invitrogen). Human GKRP (Ensembl ENST00000264717.7) was codon optimized for yeast expression and cloned into pDONR221 with an N-terminal HA-tag (Genscript). For yeast expression, GKRP was cloned into pAG415GPD-ccdB (Addgene plasmid # 14,146; http://n2t.net/addgene:14146; RRID:Addgene_14146, [92 (link)]) using Gateway cloning (Invitrogen).
+ Open protocol
+ Expand
3

Codon-Optimized Yeast GCK for DHFR-PCA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The DNA sequence of pancreatic human GCK (Ensembl ENST00000403799.8) was codon optimized for yeast and cloned into pDONR221 (Genscript). Selected missense variants were generated by Genscript. To generate a destination vector for the DHFR-PCA, a Gateway cassette was inserted at the C-terminus of DHFR[F3] in pGJJ045 (Faure et al., 2022 (link)) (Genscript). GCK was cloned into the pDEST-DHFR-PCA destination vector using Gateway cloning (Invitrogen). For the GCK activity assay, GCK was cloned into pAG416GPD-EGFP-ccdB (Addgene plasmid 14316; http://n2t.net/addgene: 14316; RRID:Addgene_14316) (Alberti et al., 2007 (link)) using Gateway cloning (Invitrogen).
+ Open protocol
+ Expand
4

Cloning and Expression of Mutant GCK

Check if the same lab product or an alternative is used in the 5 most similar protocols
The DNA sequence of pancreatic human GCK (Ensembl ENST00000403799.8) was codon optimized for yeast and cloned into pDONR221 (Genscript). Selected missense variants were generated by Genscript. To generate a destination vector for the DHFR-PCA, a Gateway cassette was inserted 3′ to DHFR[F3] and a linker in pGJJ045 [34 ] (Genscript). GCK was cloned into the pDEST-DHFR-PCA destination vector using Gateway cloning (Invitrogen), such that the N-terminus of GCK was fused to DHFR[F3] (Additional file 1: Fig. S18). For the GCK activity assay, GCK was cloned into pAG416GPD-EGFP-ccdB (Addgene plasmid 14316; http://n2t.net/addgene:14316; RRID:Addgene_14316) [52 ] using Gateway cloning (Invitrogen).
+ Open protocol
+ Expand
5

Generation of FMO1 Overexpression Construct

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to obtain genetic construct for FMO1 overexpression, total plant RNA was extracted from three-week-old wild type plants using the TRIzol reagent (Invitrogen, Life Technologies, Carlsbad, CA, USA) and purified from residual DNA with a DNA-free™ DNA Removal Kit (Ambion, Life Technologies, Carlsbad, CA, USA). The total RNA concentration was measured at 260 nm using a UV–VIS spectrophotometer (NanoDrop, Thermo Fisher Scientific, Waltham, MA, USA). cDNA synthesis was performed on 2 μg of RNA using a High Capacity cDNA Reverse Transcription Kit (Life Technologies, Carlsbad, CA, USA). Full-length FMO1 (AT1G19250) coding sequence was amplified by a polymerase chain reaction (PCR) using a Phusion HighFidelity DNA Polymerase (Thermo Fisher Scientific) on cDNA template with specific primers, extended with the attB sites for Gateway cloning (Invitrogen). Primer sequences are provided in Supplementary Table S1. The genetic construct, in which GFP-FMO1 fusion was expressed under the control of the cauliflower mosaic virus 35S promoter (p35S: GFP-FMO1) was obtained by recombinational Gateway cloning (Invitrogen) using pK7WGF2 vector [45 (link)].
+ Open protocol
+ Expand
6

Generating Drosophila S2 Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full-length SR proteins, XL6▵RS, and XL6-B52RS were PCR amplified and cloned into pDONR221 by BP reaction (Gateway cloning; Invitrogen). XL6-B52RS was amplified using a two-step PCR. First, the RRM-domain of XL6 and RS-domain of B52 were amplified, separately. Next, the purified PCR products were mixed together and amplified with outside primers to generate the fusion. Next, the constructs were inserted into a destination vector that contained the metallothionein promoter and a C-terminal 2x Flag and 2x HA tag (pMT-C2FL2HA) by LR reaction (Gateway cloning; Invitrogen).
Four hundred nanograms of pMT-C2FL2HA plasmid DNA containing full-length SR proteins, XL6▵RS, or XL6-B52RS and 40 ng of a plasmid carrying the gene for blasticidin resistance (pCO-BLAST) were transfected into 2.0 × 106Drosophila S2 cells, seeded in a six-well dish, using Effectene transfection reagent (Qiagen) according to the manufacturer's protocol. After 48 h, 25 µg/mL of blasticidin (Invivogen) was added to the cells. Resistant cells were expanded and maintained in Schneider media with 10% FBS and 25 µg/mL blasticidin.
+ Open protocol
+ Expand
7

Generation of pB7WGF2-BPC6 Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate the pB7WGF2-BPC6 constructs, the full-length cDNA of BPC6 was PCR-amplified using the primer pairs as described in Supplementary Table 2. Then the PCR products were purified, and first cloned into pDNOR201 by BP Clonase reactions (GATEWAY Cloning; Invitrogen) according to the manufacturer's instructions to generate the pDNOR-BPC6. The resulting plasmids were recombined into pB7WGF2 using LR Clonase reactions (GATEWAY Cloning; Invitrogen) to generate the final constructs.
+ Open protocol
+ Expand
8

Studying Protein-Protein Interactions via BiFC

Check if the same lab product or an alternative is used in the 5 most similar protocols
The wild-type copy of xopX and its 14-3-3 protein binding motif mutants were cloned by Gateway cloning (Invitrogen, California) from the pENTR clones to the BiFC vector pDEST-VYCE(R)GW carrying the C-terminal region of the Venus Fluorescent Protein (VFP) (Gehl et al., 2009) by Gateway® cloning (Invitrogen, California) from the pENTR clones to yield the constructs as listed in Supplementary table S2. The eight rice 14-3-3 genes cloned in the BiFC vector pDEST-VYNE(R)GW carrying the N-terminal region of VFP were used from a previous study (Deb et al., 2019) . To check for XopQ-XopX interaction, xopQ was cloned in pDEST-VYNE(R)GW. These binary vectors obtained were then electroporated into the A.
tumefaciens strain AGL1 (Supplementary table S2). A suspension of two strains expressing the gene-nVFP/cVFP fusions were grown to 0.8 O.D. 600 , resuspended in infiltration buffer (10mM MES, 10mM MgCl 2 , 100µM acetosyringone, pH 5.6) and used for transient expression in N. benthamiana. VFP signals were examined 48h after infiltration under a LSM880 confocal microscope (Carl Zeiss, Germany) using 20x objectives and He-Ne laser at 488nm excitation. Images were analyzed using the ZEN software. Each set was repeated three times.
+ Open protocol
+ Expand
9

Studying Protein-Protein Interactions via BiFC

Check if the same lab product or an alternative is used in the 5 most similar protocols
The wild-type copy of xopX and its 14-3-3 protein binding motif mutants were cloned by Gateway cloning (Invitrogen, California) from the pENTR clones to the BiFC vector pDEST-VYCE(R)GW carrying the C-terminal region of the Venus Fluorescent Protein (VFP) (Gehl et al., 2009) by Gateway® cloning (Invitrogen, California) from the pENTR clones to yield the constructs as listed in Supplementary table S2. The eight rice 14-3-3 genes cloned in the BiFC vector pDEST-VYNE(R)GW carrying the N-terminal region of VFP were used from a previous study (Deb et al., 2019) . To check for XopQ-XopX interaction, xopQ was cloned in pDEST-VYNE(R)GW. These binary vectors obtained were then electroporated into the A.
tumefaciens strain AGL1 (Supplementary table S2). A suspension of two strains expressing the gene-nVFP/cVFP fusions were grown to 0.8 O.D. 600 , resuspended in infiltration buffer (10mM MES, 10mM MgCl 2 , 100µM acetosyringone, pH 5.6) and used for transient expression in N. benthamiana. VFP signals were examined 48h after infiltration under a LSM880 confocal microscope (Carl Zeiss, Germany) using 20x objectives and He-Ne laser at 488nm excitation. Images were analyzed using the ZEN software. Each set was repeated three times.
+ Open protocol
+ Expand
10

Overexpression and Mutagenesis Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To overexpress bzr1-1D and bes1-D, the full-length bzr1-1D and bes1-D coding sequences plus 10 bp upstream of the start codon ATG were first amplified from cDNA reverse transcribed from mRNA isolated from bzr1-1D and bes1-D plants, respectively. The coding sequences were subsequently inserted downstream of the 35S promoter in pB2GW7 (Karimi et al., 2005) by Gateway cloning (Invitrogen). To construct FLAG:BIM1, the full-length BIM1 coding sequence minus the start codon was fused in frame with FLAG (at the 5 0 end) in pENTR3 (Invitrogen), and subsequently the fusion sequence was inserted downstream of the 35S promoter in pB2GW7 (Karimi et al., 2005) by Gateway cloning. For ELF6:FLAG construction, the full-length ELF6 coding sequence minus the stop codon was fused in frame with FLAG in pPZPY112 at BamHI and KpnI (Hou et al., 2010) . The oligos used for cloning are described in Supplemental Table 2.
To create FLC mE-box and FLC mBRRE , an 8.2-kb FLC genomic fragment consisting of the 1.8-kb promoter, 5.6-kb genomic coding region, and 0.8-kb 3 0 region, bearing a mutated E-box (CATATG to TCTAAA; Yin et al., 2005) or a mutated BRRE (CGTGTG to AAAAAA; He et al., 2005) in the first intron (mutated by overlapping PCR with oligos specified in Supplemental Table 2), were cloned into the binary vector pPZP212 at SalI and SacI (Hajdukiewicz et al., 1994) .
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!